Abstract:
Migration and invasion inhibitory protein (MIIP) inhibits cell proliferation, migration, and invasion, impeding tumorigenesis and tumor progression, by interacting with insulin-like growth factor binding protein 2 (IGFBP2), histone deacetylase 6 (HDAC6), p21 activated kinase 1 (PAK1), epidermal growth factor receptor (EGFR), cell division cycle 20 (CDC20), and topoisomerase. Recent studies revealed potential roles of MIIP in viral infection and cellular immunity. MIIP has become a research hotspot owing to its involvement in multiple signaling pathways and as a potential therapeutic target for tumors. This review summarizes the characteristics, functions, clinical significance, and possible pathogenic mechanisms of MIIP in multiple carcinomas.